(Q73503950)

English

Cost-effectiveness of initial therapy with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors to treat hypercholesterolemia in a primary care setting of a managed-care organization

scientific article published on 01 May 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9220221%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Cost-effectiveness of initial therapy with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors to treat hypercholesterolemia in a primary care setting of a managed-care organization (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9220221%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

M E Spearman

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9220221%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

K Summers

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9220221%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

V Moore

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9220221%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

R Jacqmin

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9220221%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

G Smith

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9220221%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

S Groshen

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9220221%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 May 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9220221%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9220221%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9220221%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9220221%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

582-602; discussion 538-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9220221%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholesterol and coronary heart disease mortality. A 23-year follow-up study of 9902 men in Israel

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Short- and long-term association of serum cholesterol with mortality. The 25-year follow-up of the Finnish cohorts of the seven countries study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of serum lipids with the presence or absence of coronary artery disease in 1,793 men and women aged > or = 62 years

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Consensus conference. Lowering blood cholesterol to prevent heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of action and biological profile of HMG CoA reductase inhibitors. A new therapeutic alternative

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluvastatin Long-Term Extension Trial (FLUENT): summary of efficacy and safety.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of primary hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Replacing lovastatin with pravastatin: effect on serum lipids and costs.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for the clinical and economic evaluation of health care technologies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic analysis of health technologies and programmes. A Spanish proposal for methodological standardisation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of confidence intervals and sample size calculations in health economic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of fluvastatin, a totally synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. FLUENT Study Group. Fluvastatin Long-Term Extension Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of fluvastatin, a new HMG CoA reductase inhibitor, in elderly hypercholesterolaemic women

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluvastatin reduces levels of plasma apo B-containing particles and increases those of LpA-I. European Fluvastatin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of primary hypercholesterolaemia. Short-term efficacy and safety of increasing doses of simvastatin and pravastatin: a double-blind comparative study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-response of simvastatin in primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980142-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(97)80142-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9220221%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9220221%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73503950&oldid=1944922614"